PW Medtech Completes Additional Buyback; 3.71 Million Shares Repurchased Under 2026 Mandate

Bulletin Express

Sep 09

PW Medtech Group Limited disclosed on 9 September 2026 that it repurchased 402,000 ordinary shares on-market at prices ranging between HKD 0.97 and HKD 0.98 per share, deploying HKD 0.39 million in aggregate. All repurchased shares are intended for cancellation.

Including this latest transaction, the company has bought back a cumulative 3.71 million shares since the current mandate was approved on 26 June 2026. The cumulative repurchases represent approximately 0.26 % of PW Medtech’s issued share capital of 1.43 billion shares, well within the 144.29 million-share limit authorised by shareholders.

The issued share count remained unchanged at 1.43 billion as of 9 September 2026 because none of the repurchased shares had yet been cancelled. PW Medtech’s buybacks have been executed at prices ranging from HKD 0.91 to HKD 1.10 per share between 29 June and 9 September 2026.

Under Hong Kong Stock Exchange rules, the company is subject to a moratorium on issuing new shares until 9 October 2026 following the most recent repurchase. PW Medtech confirmed that all repurchases were conducted in compliance with the exchange’s regulations and the terms of its April 24 Explanatory Statement.

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

1
2
3
4
5
6
7
8
9
10

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers | Global Stocks, Options & Futures Trading App","description":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","keywords":"tiger brokers,tiger trade,tiger brokers singapore,broker online,stock trading in singapore,share trading singapore,brokerage firm singapore,trading app,stock broker singapore,stock trading platforms,trading account","social":{"ogDescription":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.0a0bd8dc.png","ogUrl":"https://www.itiger.com/news/1186663673"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental"},"isCrawlerRequest":true,"__swrFallback__":{"@#url:\"https://stock-news.skytigris.cn/v3/news\",params:#id:\"1186663673\",edition:\"fundamental\",auth_exemption:1,,,undefined,":{"share":"https://ttm.financial/m/news/1186663673?lang=en_US&edition=fundamental","thumbnail":"","is_english":true,"pubTime":"2026-09-09 19:40","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"1186663673","market":"hk","top_or_hot":-1,"title":"PW Medtech Completes Additional Buyback; 3.71 Million Shares Repurchased Under 2026 Mandate","media":"Bulletin Express","content":"<p>PW Medtech Group Limited disclosed on 9 September 2026 that it repurchased 402,000 ordinary shares on-market at prices ranging between HKD 0.97 and HKD 0.98 per share, deploying HKD 0.39 million in aggregate. All repurchased shares are intended for cancellation.</p>\n<p>Including this latest transaction, the company has bought back a cumulative 3.71 million shares since the current mandate was approved on 26 June 2026. The cumulative repurchases represent approximately 0.26 % of PW Medtech’s issued share capital of 1.43 billion shares, well within the 144.29 million-share limit authorised by shareholders.</p>\n<p>The issued share count remained unchanged at 1.43 billion as of 9 September 2026 because none of the repurchased shares had yet been cancelled. PW Medtech’s buybacks have been executed at prices ranging from HKD 0.91 to HKD 1.10 per share between 29 June and 9 September 2026.</p>\n<p>Under Hong Kong Stock Exchange rules, the company is subject to a moratorium on issuing new shares until 9 October 2026 following the most recent repurchase. PW Medtech confirmed that all repurchases were conducted in compliance with the exchange’s regulations and the terms of its April 24 Explanatory Statement.</p>","source":null,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>PW Medtech Completes Additional Buyback; 3.71 Million Shares Repurchased Under 2026 Mandate</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nPW Medtech Completes Additional Buyback; 3.71 Million Shares Repurchased Under 2026 Mandate\n</h2>\n\n<h4 class=\"meta\">\n\n\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1053168898\">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://community-static.tradeup.com/news/ed558ed0402cbe7d1ef4d150458f2b2e);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Bulletin Express </p>\n<p class=\"h-time\">2026-09-09 19:40</p>\n</div>\n\n</a>\n\n\n</h4>\n\n</header>\n<article>\n<p>PW Medtech Group Limited disclosed on 9 September 2026 that it repurchased 402,000 ordinary shares on-market at prices ranging between HKD 0.97 and HKD 0.98 per share, deploying HKD 0.39 million in aggregate. All repurchased shares are intended for cancellation.</p>\n<p>Including this latest transaction, the company has bought back a cumulative 3.71 million shares since the current mandate was approved on 26 June 2026. The cumulative repurchases represent approximately 0.26 % of PW Medtech’s issued share capital of 1.43 billion shares, well within the 144.29 million-share limit authorised by shareholders.</p>\n<p>The issued share count remained unchanged at 1.43 billion as of 9 September 2026 because none of the repurchased shares had yet been cancelled. PW Medtech’s buybacks have been executed at prices ranging from HKD 0.91 to HKD 1.10 per share between 29 June and 9 September 2026.</p>\n<p>Under Hong Kong Stock Exchange rules, the company is subject to a moratorium on issuing new shares until 9 October 2026 following the most recent repurchase. PW Medtech confirmed that all repurchases were conducted in compliance with the exchange’s regulations and the terms of its April 24 Explanatory Statement.</p>\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"01358","symbol_name":"普华和顺","start_time":0,"source_url":"","article_id":"1186663673","we_media_id":"1053168898","thumbnails":[],"rights":null,"url":"https://stock-news.laohu8.com/highlight/detail?id=1186663673","pubTimestamp":1788954038,"columns":[],"sourceInfo":null,"weMediaInfo":{"media_name":"Bulletin Express","introduction":"Full Coverage of HK & US Stock Announcements","home_visible":1,"id":"1053168898","head_image":"https://community-static.tradeup.com/news/ed558ed0402cbe7d1ef4d150458f2b2e"},"summary":"PW Medtech Group Limited disclosed on 9 September 2026 that it repurchased 402,000 ordinary shares on-market at prices ranging between HKD 0.97 and HKD 0.98 per share, deploying HKD 0.39 million in...","collect":0,"end_time":0,"defaultTopTitle":"","property":[],"viewcount":null,"language":"en","relate_stocks":{"01358":"普华和顺"},"translate_title":"PW Medtech 完成额外回购；根据 2026 年授权回购 371 万股股票","themeId":null,"isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"01358":1},"content_text":"PW Medtech Group Limited disclosed on 9 September 2026 that it repurchased 402,000 ordinary shares on-market at prices ranging between HKD 0.97 and HKD 0.98 per share, deploying HKD 0.39 million in aggregate. All repurchased shares are intended for cancellation.\nIncluding this latest transaction, the company has bought back a cumulative 3.71 million shares since the current mandate was approved on 26 June 2026. The cumulative repurchases represent approximately 0.26 % of PW Medtech’s issued share capital of 1.43 billion shares, well within the 144.29 million-share limit authorised by shareholders.\nThe issued share count remained unchanged at 1.43 billion as of 9 September 2026 because none of the repurchased shares had yet been cancelled. PW Medtech’s buybacks have been executed at prices ranging from HKD 0.91 to HKD 1.10 per share between 29 June and 9 September 2026.\nUnder Hong Kong Stock Exchange rules, the company is subject to a moratorium on issuing new shares until 9 October 2026 following the most recent repurchase. PW Medtech confirmed that all repurchases were conducted in compliance with the exchange’s regulations and the terms of its April 24 Explanatory Statement.","kind":"news","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":true,"editions":null,"column":"","sentiment":"1","news_tag":"shareholding,SGX","news_rank":0,"isVideo":false,"video":null,"symbols":[],"gpt_button":0,"need_auth":false,"need_login_tip":false,"code":"91000000","status":"200"}}}